Improved capsular polysaccharide production by Streptococcus pneumoniae serotype 14 using continuous cultivation

被引:4
|
作者
Rodege Gogola-Kolling, Veronica Maria [1 ]
Zanardo, Rafaela Tais [1 ]
Carmo, Talita Souza [1 ]
Zampoli, Natalia Dalfre [1 ]
Figueiredo, Douglas Borges [1 ]
Goncalves, Viviane Maimoni [1 ]
机构
[1] Inst Butantan, Ctr Biotecnol, Lab Bioproc, BR-05503900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Pneumococcus; Continuous culture; Batch processing; Production kinetics; Microbial growth; Kinetic parameters; PROTEIN-A PSPA; LACTOCOCCUS-LACTIS; CONTINUOUS-CULTURE; MOLECULAR ANALYSIS; ACID FERMENTATION; GROWTH; OPTIMIZATION; GLUCOSE; BIOSYNTHESIS; CONJUGATION;
D O I
10.1016/j.bej.2014.07.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The capsular polysaccharide (PS) is the most important pneumococcal virulence factor and is currently used as antigen in all pneumococcal vaccines. Despite its physiological and epidemiological importance, meager studies have been devoted to improve PS production and understand its relationship with pneumococcal central metabolism. In this study, kinetics of growth and production of PS by Streptococcus pneumoniae serotype 14 (PS14) in batch and continuous cultivation were investigated. Strong cell lysis was observed in batch cultivation, while accumulation of organic acids and autolysis was avoided in continuous cultivation. In the continuous cultivation was possible to achieve higher concentration of biomass and PS14. Calculation of kinetic parameters demonstrated that PS14 is a cell-associated product. The coefficients for growth-associated stoichiometric true yield and maintenance were determined as 0.25 g(glucose)g(biomass)(-1) and 1.24g(glucose) (g(biomass) h)(-1), respectively. The maximum productivity of PS14 released in the supernatant (PS14(R)) and cell-bound PS14 (PS14(c)) were obtained at a dilution rate of 0.8 h(-1), respectively, 85 and 122 mg (g(biomass) h)(-1). Compared to batch fermentation, both PS14(R) and PS14(c) productivities were increased by about 300% in the continuous process. These findings demonstrate that continuous cultivation is a promising strategy for PS production to be used in pneumococcal vaccines. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [31] Immunochemical and Protective Properties of Conjugated Capsular Polysaccharide of Streptococcus pneumoniae Serotype 9N
    R. I. Nuriev
    I. A. Galvidis
    N. E. Yastrebova
    M. A. Burkin
    Applied Biochemistry and Microbiology, 2018, 54 : 869 - 875
  • [32] NMR structural analysis of the capsular polysaccharide from Streptococcus pneumoniae serotype 6C
    Cai, Ping
    Moran, Justin
    Pavliak, Viliam
    Deng, Chenghua
    Khoury, Nancy
    Marcq, Olivier
    Ruppen, Mark E.
    CARBOHYDRATE RESEARCH, 2012, 351 : 98 - 107
  • [33] A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide
    Sari, Ratna Fathma
    Fadilah, Fadilah
    Maladan, Yustinus
    Sarassari, Rosantia
    Safari, Dodi
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2024, 13 (02) : 91 - 104
  • [34] Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains
    Gonzales-Siles, Lucia
    Salva-Serra, Francisco
    Degerman, Anna
    Norden, Rickard
    Lindh, Magnus
    Skovbjerg, Susann
    Moore, Edward R. B.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (08) : 1173 - 1188
  • [35] SYNTHESIS OF STRUCTURAL ELEMENTS OF THE CAPSULAR POLYSACCHARIDE OF STREPTOCOCCUS-PNEUMONIAE TYPE-14
    KOEMAN, FAW
    MEISSNER, JWG
    VANRITTER, HRP
    KAMERLING, JP
    VLIEGENTHART, JFG
    JOURNAL OF CARBOHYDRATE CHEMISTRY, 1994, 13 (01) : 1 - 25
  • [36] Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide
    Zhong, Z
    Burns, T
    Chang, Q
    Carroll, M
    Pirofski, L
    INFECTION AND IMMUNITY, 1999, 67 (08) : 4119 - 4127
  • [37] Chemical Synthesis Elucidates the Immunological Importance of a Pyruvate Modification in the Capsular Polysaccharide of Streptococcus pneumoniae Serotype 4
    Pereira, Claney L.
    Geissner, Andreas
    Anish, Chakkumkal
    Seeberger, Peter H.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (34) : 10016 - 10019
  • [38] The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages
    Fabrizio, Kevin
    Manix, Catherine
    Tian, Haijun
    van Rooijen, Nico
    Pirofski, Liise-anne
    VACCINE, 2010, 28 (47) : 7542 - 7550
  • [39] Synthesis and Immunological Studies of Oligosaccharides that Consist of the Repeating Unit of Streptococcus pneumoniae Serotype 3 Capsular Polysaccharide
    Xiong, Chenghe
    Feng, Shaojie
    Qiao, Yin
    Guo, Zhongwu
    Gu, Guofeng
    CHEMISTRY-A EUROPEAN JOURNAL, 2018, 24 (32) : 8205 - 8216
  • [40] Identification of the common antigenic determinant shared by Streptococcus pneumoniae serotypes 35A and 20 capsular polysaccharides - Structural analysis of the Streptococcus pneumoniae serotype 35A capsular polysaccharide
    Beynon, LM
    Richards, JC
    Perry, MB
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01): : 163 - 167